{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,21]],"date-time":"2026-08-21T06:26:16Z","timestamp":1787293576300,"version":"build-2736575974"},"reference-count":118,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2026,6,24]],"date-time":"2026-06-24T00:00:00Z","timestamp":1782259200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,6,24]],"date-time":"2026-06-24T00:00:00Z","timestamp":1782259200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Endocrinol Invest"],"DOI":"10.1007\/s40618-026-02882-8","type":"journal-article","created":{"date-parts":[[2026,6,24]],"date-time":"2026-06-24T03:57:22Z","timestamp":1782273442000},"page":"2113-2134","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Practical approach to the diagnosis, management, and treatment of pediatric patients with bone fragility: an expert opinion"],"prefix":"10.1007","volume":"49","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8465-5087","authenticated-orcid":false,"given":"Giampiero I.","family":"Baroncelli","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6484-4371","authenticated-orcid":false,"given":"Daniele","family":"Tessaris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1754-6822","authenticated-orcid":false,"given":"Tommaso","family":"Aversa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9597-833X","authenticated-orcid":false,"given":"Enrica","family":"Bertelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5209-9733","authenticated-orcid":false,"given":"Pasquale","family":"Comberiati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3628-1612","authenticated-orcid":false,"given":"Domenico","family":"Corica","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4492-4585","authenticated-orcid":false,"given":"Natascia","family":"Di Iorgi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1899-8337","authenticated-orcid":false,"given":"Maria Felicia","family":"Faienza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0103-7951","authenticated-orcid":false,"given":"Danilo","family":"Fintini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2230-7148","authenticated-orcid":false,"given":"Roberto","family":"Franceschi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6343-4768","authenticated-orcid":false,"given":"Anna","family":"Grandone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-2186-9853","authenticated-orcid":false,"given":"Mila Ann","family":"Karapurackal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-3979-2857","authenticated-orcid":false,"given":"Silvia","family":"Longhi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-2753-9230","authenticated-orcid":false,"given":"Marco","family":"Pitea","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-2921-9894","authenticated-orcid":false,"given":"Andrea","family":"Secco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8292-9494","authenticated-orcid":false,"given":"Giuliana","family":"Trifir\u00f2","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-2134-6639","authenticated-orcid":false,"given":"Graziamaria","family":"Ubertini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9985-7084","authenticated-orcid":false,"given":"Flavia","family":"Urbano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2192-518X","authenticated-orcid":false,"given":"Francesco","family":"Vierucci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8299-2677","authenticated-orcid":false,"given":"Malgorzata","family":"Wasniewska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4781-6715","authenticated-orcid":false,"given":"Stefano","family":"Mora","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2113-6196","authenticated-orcid":false,"given":"Luisa","family":"de Sanctis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,24]]},"reference":[{"key":"2882_CR1","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1097\/01202412-199704000-00002","volume":"6","author":"LA Landin","year":"1997","unstructured":"Landin LA (1997) Epidemiology of children\u2019s fractures. J Pediatr Orthop B 6:79\u201383. https:\/\/doi.org\/10.1097\/01202412-199704000-00002","journal-title":"J Pediatr Orthop B"},{"key":"2882_CR2","doi-asserted-by":"publisher","first-page":"990","DOI":"10.1007\/s001980200137","volume":"13","author":"IE Jones","year":"2002","unstructured":"Jones IE, Williams SM, Dow N, Goulding A (2002) How many children remain fracture-free during growth? a longitudinal study of children and adolescents participating in the Dunedin multidisciplinary Health and development study. Osteoporos Int 13:990\u2013995. https:\/\/doi.org\/10.1007\/s001980200137","journal-title":"Osteoporos Int"},{"key":"2882_CR3","first-page":"1","volume":"202","author":"LA Landin","year":"1983","unstructured":"Landin LA (1983) Fracture patterns in children. Analysis of 8,682 fractures with special reference to incidence, etiology and secular changes in a Swedish urban population 1950\u20131979. Acta Orthop Scand Suppl 202:1\u2013109 (PMID:6574687)","journal-title":"Acta Orthop Scand Suppl"},{"key":"2882_CR4","doi-asserted-by":"publisher","first-page":"1479","DOI":"10.1001\/jama.290.11.1479","volume":"290","author":"S Khosla","year":"2003","unstructured":"Khosla S, Melton LJ, Dekutoski MB, Achenbach SJ, Oberg AL, Riggs BL (2003) Incidence of childhood distal forearm fractures over 30 years: a population-based study. JAMA 290:1479\u20131485. https:\/\/doi.org\/10.1001\/jama.290.11.1479","journal-title":"JAMA"},{"key":"2882_CR5","doi-asserted-by":"publisher","first-page":"1943","DOI":"10.1210\/jc.2010-2546","volume":"96","author":"AM Boyce","year":"2011","unstructured":"Boyce AM, Gafni RI (2011) Approach to the child with fractures. J Clin Endocrinol Metab 96:1943\u20131952. https:\/\/doi.org\/10.1210\/jc.2010-2546","journal-title":"J Clin Endocrinol Metab"},{"key":"2882_CR6","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2023.1266986","volume":"14","author":"LM Ward","year":"2024","unstructured":"Ward LM (2024) A practical guide to the diagnosis and management of osteoporosis in childhood and adolescence. Front Endocrinol 14:1266986. https:\/\/doi.org\/10.3389\/fendo.2023.1266986","journal-title":"Front Endocrinol"},{"key":"2882_CR7","doi-asserted-by":"publisher","first-page":"1435","DOI":"10.1002\/jbmr.3447","volume":"33","author":"LM Ward","year":"2018","unstructured":"Ward LM, Ma J, Lang B, Ho J, Alos N, Matzinger MA, Shenouda N, Lentle B, Jaremko JL, Wilson B, Stephure D, Stein R et al (2018) Bone morbidity and recovery in children with acute lymphoblastic leukemia: results of a six-year prospective cohort study. J Bone Miner Res 33:1435\u20131443. https:\/\/doi.org\/10.1002\/jbmr.3447","journal-title":"J Bone Miner Res"},{"key":"2882_CR8","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1016\/j.jocd.2019.07.002","volume":"22","author":"DR Weber","year":"2019","unstructured":"Weber DR, Boyce A, Gordon C, Hogler W, Kecskemethy HH, Misra M, Swolin-Eide D, Tebben P, Ward LM, Wasserman H, Shuhart C, Zemelet BS (2019) The utility of DXA assessment at the forearm, proximal femur and lateral distal femur and vertebral fracture assessment in the pediatric population the 2019 official pediatric positions of the ISCD. J Clin Densitom 22:567\u2013589. https:\/\/doi.org\/10.1016\/j.jocd.2019.07.002","journal-title":"J Clin Densitom"},{"key":"2882_CR9","doi-asserted-by":"publisher","first-page":"1137","DOI":"10.1002\/jbmr.5650080915","volume":"8","author":"HK Genant","year":"1993","unstructured":"Genant HK, Wu CY, van Kuijk C, Nevitt MC (1993) Vertebral fracture assessment using a semiquantitative technique. J Bone Miner Res 8:1137\u20131148. https:\/\/doi.org\/10.1002\/jbmr.5650080915","journal-title":"J Bone Miner Res"},{"key":"2882_CR10","doi-asserted-by":"publisher","first-page":"e2024070074","DOI":"10.1542\/peds.2024-070074","volume":"155","author":"S Haney","year":"2025","unstructured":"Haney S, Scherl S, DiMeglio L, Perez-Rossello J, Servaes S, Merchant N, The council on child abuse and neglect; section on orthopaedics; section on radiology; and section on endocrinology; and the society for pediatric radiology (2025) Evaluating young children with fractures f, or child abuse: clinical report. Pediatrics 155:e2024070074. https:\/\/doi.org\/10.1542\/peds.2024-070074","journal-title":"Pediatrics"},{"key":"2882_CR11","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1007\/s00247-018-4279-5","volume":"49","author":"FF Alqahtani","year":"2019","unstructured":"Alqahtani FF, Offiah AC (2019) Diagnosis of osteoporotic vertebral fractures in children. Pediatr Radiol 49:283\u2013296. https:\/\/doi.org\/10.1007\/s00247-018-4279-5","journal-title":"Pediatr Radiol"},{"key":"2882_CR12","doi-asserted-by":"publisher","first-page":"2549","DOI":"10.1007\/s00431-022-04455-2","volume":"181","author":"S Ciancia","year":"2022","unstructured":"Ciancia S, van Rijn RR, H\u00f6gler W, Appelman\u2010Dijkstra NM, Boot AM, Sas TCJ, Renes JS (2022) Osteoporosis in children and adolescents: when to suspect and how to diagnose it. Eur J Pediatr 181:2549\u20132561. https:\/\/doi.org\/10.1007\/s00431-022-04455-2","journal-title":"Eur J Pediatr"},{"key":"2882_CR13","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1016\/j.beem.2018.06.002","volume":"32","author":"N Di Iorgi","year":"2018","unstructured":"Di Iorgi N, Maruca K, Patti G, Mora S (2018) Update on bone density measurements and their interpretation in children and adolescents. Best Pract Res Clin Endocrinol Metab 32:477\u2013498. https:\/\/doi.org\/10.1016\/j.beem.2018.06.002","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"key":"2882_CR14","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/j.jocd.2020.01.0067","volume":"24","author":"CE Guss","year":"2021","unstructured":"Guss CE, McAllister A, Gordon CM (2021) DXA in children and adolescents. J Clin Densitom 24:28\u201335. https:\/\/doi.org\/10.1016\/j.jocd.2020.01.0067","journal-title":"J Clin Densitom"},{"key":"2882_CR15","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1159\/000076635","volume":"61","author":"E Schoenau","year":"2004","unstructured":"Schoenau E, Saggese G, Peter F, Baroncelli GI, Shaw NJ, Crabtree NJ, Zadik Z, Neu CM, Noordam C, Radetti G, Hochberg Z (2004) From biology to bone analysis. Horm Res 61:257\u2013269. https:\/\/doi.org\/10.1159\/000076635","journal-title":"Horm Res"},{"key":"2882_CR16","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1002\/jbmr.5650070204","volume":"7","author":"DR Carter","year":"1992","unstructured":"Carter DR, Bouxsein ML, Marcus R (1992) New approaches for interpreting projected bone densitometry data. J Bone Miner Res 7:137\u2013145. https:\/\/doi.org\/10.1002\/jbmr.5650070204","journal-title":"J Bone Miner Res"},{"key":"2882_CR17","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/0169-6009(92)90712-m","volume":"17","author":"H Kroger","year":"1992","unstructured":"Kroger H, Kotaniemi A, Vainio P, Alhava E (1992) Bone densitometry of the spine and femur in children by dual-energy X-ray absorptiometry. Bone Miner 17:75\u201385. https:\/\/doi.org\/10.1016\/0169-6009(92)90712-m","journal-title":"Bone Miner"},{"key":"2882_CR18","doi-asserted-by":"publisher","first-page":"3160","DOI":"10.1210\/jc.2011-1111","volume":"96","author":"BS Zemel","year":"2011","unstructured":"Zemel BS, Kalkwarf H, Gilsanz V, Lappe JM, Oberfield S, Shepherd JA, Frederick MM, Huang X, Lu M, Mahboubi S, Hangartner T, Winer KK (2011) Revised reference curves for bone mineral content and areal bone mineral density according to age and sex for Black and non-Black children: results of the bone mineral density in childhood study. J Clin Endocrinol Metab 96:3160\u20133169. https:\/\/doi.org\/10.1210\/jc.2011-1111","journal-title":"J Clin Endocrinol Metab"},{"issue":"Suppl 1","key":"2882_CR19","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1159\/000063441","volume":"54","author":"GI Baroncelli","year":"2000","unstructured":"Baroncelli GI, Saggese G (2000) Critical ages and stages of puberty in the accumulation of spinal and femoral bone mass: the validity of bone mass measurements. Horm Res 54(Suppl 1):2\u20138. https:\/\/doi.org\/10.1159\/000063441","journal-title":"Horm Res"},{"key":"2882_CR20","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1007\/s11914-023-00811-9","volume":"21","author":"L Gabel","year":"2023","unstructured":"Gabel L, Kent K, Hosseinitabatabaei S, Burghardt AJ, Leonard MB, Rauch F, Willie BM (2023) Recommendations for high-resolution peripheral quantitative computed tomography assessment of bone density, microarchitecture, and strength in pediatric populations. Curr Osteoporos Rep 21:609\u2013623. https:\/\/doi.org\/10.1007\/s11914-023-00811-9","journal-title":"Curr Osteoporos Rep"},{"key":"2882_CR21","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1007\/s00223001119","volume":"67","author":"MH Lequin","year":"2000","unstructured":"Lequin MH, van Rijn RR, Robben SGF, Hop WCJ, van Kuijk C (2000) Normal values for tibial quantitative ultrasonometry in Caucasian children and adolescents (aged 6 to 19 years). Calcif Tissue Int 67:101\u2013105. https:\/\/doi.org\/10.1007\/s00223001119","journal-title":"Calcif Tissue Int"},{"key":"2882_CR22","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1016\/j.bone.2005.12.010","volume":"39","author":"GI Baroncelli","year":"2006","unstructured":"Baroncelli GI, Federico G, Vignolo M, Valerio G, del Puente A, Maghnie M, Baserga M, Farello G, Saggese G, The phalangeal quantitative ultrasound group (2006) Cross-sectional reference data for phalangeal quantitative ultrasound from early childhood to young-adulthood according to gender, age, skeletal growth, and pubertal development. Bone 39:159\u2013173. https:\/\/doi.org\/10.1016\/j.bone.2005.12.010","journal-title":"Bone"},{"key":"2882_CR23","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1007\/s40477-021-00624","volume":"25","author":"A Tummolo","year":"2022","unstructured":"Tummolo A, Brunetti G, Giordano M, Carbone V, Faienza MF, Aric\u00f2 M, Pesce S (2022) The use of quantitative ultrasound in a tertiary-level children hospital: role in the follow-up of chronically ill patients. J Ultrasound 25:563\u2013570. https:\/\/doi.org\/10.1007\/s40477-021-00624","journal-title":"J Ultrasound"},{"key":"2882_CR24","doi-asserted-by":"publisher","first-page":"1164","DOI":"10.1002\/ajmg.a.63132","volume":"191","author":"S Unger","year":"2023","unstructured":"Unger S, Ferreira CR, Mortier GR, Ali H, Bertola DR, Calder A, Cohn DH, Cormier-Daire V, Girisha KM, Hall C, Krakow D, Makitie O et al (2023) Nosology of genetic skeletal disorders: 2023 revision. Am J Med Genet 191:1164\u20131209. https:\/\/doi.org\/10.1002\/ajmg.a.63132","journal-title":"Am J Med Genet"},{"key":"2882_CR25","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1186\/s13073-022-01026-w","volume":"14","author":"S Marwaha","year":"2022","unstructured":"Marwaha S, Knowles JW, Ashley EA (2022) A guide for the diagnosis of rare and undiagnosed disease: beyond the exome. Genome Med 14:23. https:\/\/doi.org\/10.1186\/s13073-022-01026-w","journal-title":"Genome Med"},{"key":"2882_CR26","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1186\/s13073-022-01069-z","volume":"14","author":"G Schobers","year":"2022","unstructured":"Schobers G, Schieving JH, Yntema HG, Pennings M, Pfund R, Derks R, Hofste T, de Wijs I, Wieskamp N, van den Heuvel S, Galbany JC, Gilissen C et al (2022) Reanalysis of exome negative patients with rare disease: a pragmatic workflow for diagnostic applications. Genome Med 14:66. https:\/\/doi.org\/10.1186\/s13073-022-01069-z","journal-title":"Genome Med"},{"key":"2882_CR27","doi-asserted-by":"publisher","first-page":"1154","DOI":"10.1038\/s41431-023-01425-6","volume":"31","author":"T Bartolomaeus","year":"2023","unstructured":"Bartolomaeus T, Hentschel J, Jamra RA, Popp B (2023) Re-evaluation and re-analysis of 152 research exomes five years after the initial report reveals clinically relevant changes in 18%. Eur J Hum Genet 31:1154\u20131164. https:\/\/doi.org\/10.1038\/s41431-023-01425-6","journal-title":"Eur J Hum Genet"},{"key":"2882_CR28","doi-asserted-by":"publisher","first-page":"891","DOI":"10.1007\/s00223-024-01266-5","volume":"115","author":"M Jovanovic","year":"2024","unstructured":"Jovanovic M, Marini JC (2024) Update on the genetics of osteogenesis imperfecta. Calcif Tissue Int 115:891\u2013914. https:\/\/doi.org\/10.1007\/s00223-024-01266-5","journal-title":"Calcif Tissue Int"},{"key":"2882_CR29","doi-asserted-by":"publisher","first-page":"1623","DOI":"10.1002\/jbmr.4668","volume":"37","author":"A Costantini","year":"2022","unstructured":"Costantini A, Makitie RE, Hartmann MA, Fratzl-Zelman N, Zillikens MC, Kornak U, Soe K, Makitie O (2022) Early-onset osteoporosis: rare monogenic forms elucidate the complexity of disease pathogenesis beyond type I collagen. J Bone Miner Res 37:1623\u20131641. https:\/\/doi.org\/10.1002\/jbmr.4668","journal-title":"J Bone Miner Res"},{"key":"2882_CR30","doi-asserted-by":"publisher","DOI":"10.1002\/jbm4.10509","volume":"5","author":"RE Makitie","year":"2021","unstructured":"Makitie RE, Henning P, Jiu Y, Kampe A, Kogan K, Costantini A, Valimaki VV, Medina-Gomez C, Pekkinen M, Salusky IB, Schalin-Jantti C, Haanpaa M et al (2021) An ARHGAP25 variant links aberrant Rac1 function to early-onset skeletal fragility. JBMR Plus 5:e10509. https:\/\/doi.org\/10.1002\/jbm4.10509","journal-title":"JBMR Plus"},{"key":"2882_CR31","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1016\/8756-3282(94)90280-1","volume":"15","author":"S Khosla","year":"1994","unstructured":"Khosla S, Lufkin EG, Hodgson SF, Fitzpatrick LA, Melton LJ (1994) Epidemiology and clinical features of osteoporosis in young individuals. Bone 15:551\u2013555. https:\/\/doi.org\/10.1016\/8756-3282(94)90280-1","journal-title":"Bone"},{"key":"2882_CR32","doi-asserted-by":"publisher","first-page":"R185","DOI":"10.1530\/EJE-14-0865","volume":"173","author":"V Saraff","year":"2015","unstructured":"Saraff V, Hogler W (2015) Osteoporosis in children: diagnosis and management. Eur J Endocrinol 173:R185\u2013R197. https:\/\/doi.org\/10.1530\/EJE-14-0865","journal-title":"Eur J Endocrinol"},{"key":"2882_CR33","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1186\/s12969-020-0411-9","volume":"18","author":"R Galindo-Zavala","year":"2020","unstructured":"Galindo-Zavala R, Bou-Torrent R, Magallares-L\u00f3pez B, Mir-Perell\u00f3 C, Palmou-Fontana N, Sevilla-P\u00e9rez B, Medrano-San Ildefonso M, Gonz\u00e1lez-Fern\u00e1ndez MI, Rom\u00e1n-Pascua A, Alca\u00f1iz-Rodr\u00edguez P, Nieto-Gonzalez JC, L\u00f3pez-Corbeto M, Gra\u00f1a-Gil J (2020) Expert panel consensus recommendations for diagnosis and treatment of secondary osteoporosis in children. Pediatr Rheumatol 18:20. https:\/\/doi.org\/10.1186\/s12969-020-0411-9","journal-title":"Pediatr Rheumatol"},{"key":"2882_CR34","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1186\/s13023-020-01611-5","volume":"16","author":"L Masi","year":"2021","unstructured":"Masi L, Ferrari S, Javaid MK, Papapoulos S, Pierroz DD, Brandi ML, IOF skeletal rare diseases working group (2021) Bone fragility in patients affected by congenital diseases non skeletal in origin. Orphanet J Rare Dis 16:11. https:\/\/doi.org\/10.1186\/s13023-020-01611-5","journal-title":"Orphanet J Rare Dis"},{"key":"2882_CR35","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1007\/s11914-021-00667-x","volume":"19","author":"LM Ward","year":"2021","unstructured":"Ward LM (2021) Part I: which child with a chronic disease needs bone health monitoring? Curr Osteoporos Rep 19:278\u2013288. https:\/\/doi.org\/10.1007\/s11914-021-00667-x","journal-title":"Curr Osteoporos Rep"},{"key":"2882_CR36","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1007\/s40618-023-02179-0","volume":"47","author":"MM Formosa","year":"2024","unstructured":"Formosa MM, Christou MA, Makitie O (2024) Bone fragility and osteoporosis in children and young aduls. J Endocrinol Invest 47:285\u2013298. https:\/\/doi.org\/10.1007\/s40618-023-02179-0","journal-title":"J Endocrinol Invest"},{"key":"2882_CR37","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2020.00576","volume":"11","author":"LM Ward","year":"2020","unstructured":"Ward LM (2020) Glucocorticoid-induced osteoporosis: why kids are different. Front Endocrinol 11:576. https:\/\/doi.org\/10.3389\/fendo.2020.00576","journal-title":"Front Endocrinol"},{"key":"2882_CR38","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1210\/clinem\/dgae507","volume":"110","author":"LM Ward","year":"2025","unstructured":"Ward LM, Bakhamis SA, Kouiok K (2025) Approach to the pediatric patient with glucocorticoid-induced osteoporosis. J Clin Endocrinol Metab 110:572\u2013591. https:\/\/doi.org\/10.1210\/clinem\/dgae507","journal-title":"J Clin Endocrinol Metab"},{"key":"2882_CR39","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1111\/jpc.13768","volume":"54","author":"PJ Simm","year":"2018","unstructured":"Simm PJ, Biggin A, Zacharin MR, Rodda CP, Tham E, Siafarikas A, Jefferies C, Hofman PL, Jensen DE, Woodhead H, Brown J, Wheeler BJ, Brookes D, Lafferty A, Munns CF, On behalf of the APEG Bone Mineral Working Group (2018) Consensus guidelines on the use of bisphosphonate therapy in children and adolescents. J Paediatr Child Health 54:223\u2013233. https:\/\/doi.org\/10.1111\/jpc.13768","journal-title":"J Paediatr Child Health"},{"key":"2882_CR40","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1007\/s11914-021-00672-0","volume":"19","author":"LM Ward","year":"2021","unstructured":"Ward LM (2021) Part 2 when should bisphosphonates be used in children with chronic illness osteoporosis. Curr Osteoporos Rep 19:289\u2013297. https:\/\/doi.org\/10.1007\/s11914-021-00672-0","journal-title":"Curr Osteoporos Rep"},{"key":"2882_CR41","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1016\/j.anpede.2022.07.001","volume":"97","author":"RG Zavala","year":"2022","unstructured":"Zavala RG, Bou-Torrent R, Mir-Perell\u00f3 C, Mart\u00ednez Regueira S, Magallares-L\u00f3pez B, L\u00f3pez-Corbeto M, en representaci\u00f3n del grupo de trabajo de osteog\u00e9nesis imperfecta y osteoporosis infantil secundaria de la sociedad espa\u00f1ola de reumatolog\u00eda pedi\u00e1trica (2022) Effectiveness and safety of bisphosphonates therapy in secondary osteoporosis in children. An Pediatr (Engl Ed) 97:190\u2013198. https:\/\/doi.org\/10.1016\/j.anpede.2022.07.001","journal-title":"An Pediatr (Engl Ed)"},{"key":"2882_CR42","doi-asserted-by":"publisher","first-page":"4951","DOI":"10.3390\/jcm13164951","volume":"13","author":"G Cannalire","year":"2024","unstructured":"Cannalire G, Biasucci G, Bertolini L, Patianna V, Petraroli M, Pilloni S, Esposito S, Street ME (2024) Osteoporosis and bone fragility in children: diagnostic and treatment strategies. J Clin Med 13:4951. https:\/\/doi.org\/10.3390\/jcm13164951","journal-title":"J Clin Med"},{"key":"2882_CR43","doi-asserted-by":"publisher","first-page":"812","DOI":"10.1007\/s00223-024-01202-7","volume":"115","author":"P Arundel","year":"2024","unstructured":"Arundel P, Bishop N (2024) Medical management for fracture prevention in children with osteogenesis imperfecta. Calcif Tissue Int 115:812\u2013827. https:\/\/doi.org\/10.1007\/s00223-024-01202-7","journal-title":"Calcif Tissue Int"},{"key":"2882_CR44","doi-asserted-by":"publisher","first-page":"1107","DOI":"10.1002\/pbc.25942","volume":"63","author":"LC Dal Osto","year":"2016","unstructured":"Dal Osto LC, Konji VN, Halton J, Matzinger MA, Bassal M, Rauch F, Ward LM (2016) The spectrum of recovery from fracture-induced vertebral deformity in pediatric leukemia. Pediatr Blood Cancer 63:1107\u20131110. https:\/\/doi.org\/10.1002\/pbc.25942","journal-title":"Pediatr Blood Cancer"},{"key":"2882_CR45","doi-asserted-by":"publisher","first-page":"1235","DOI":"10.1359\/JBMR.050213","volume":"20","author":"CF Munns","year":"2005","unstructured":"Munns CF, Rauch F, Travers R, Glorieux FH (2005) Effects of intravenous pamidronate treatment in infants with osteogenesis imperfecta: clinical and histomorphometric outcome. J Bone Miner Res 20:1235\u20131243. https:\/\/doi.org\/10.1359\/JBMR.050213","journal-title":"J Bone Miner Res"},{"key":"2882_CR46","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1159\/000331128","volume":"76","author":"O Semler","year":"2011","unstructured":"Semler O, Beccard R, Palmisano D, Demant A, Fricke O, Schoenau E, Koerber F (2011) Reshaping of vertebrae during treatment with neridronate or pamidronate in children with osteogenesis imperfecta. Horm Res Paediatr 76:321\u2013327. https:\/\/doi.org\/10.1159\/000331128","journal-title":"Horm Res Paediatr"},{"key":"2882_CR47","doi-asserted-by":"publisher","first-page":"2150","DOI":"10.1002\/jbmr.2567","volume":"30","author":"T Palomo","year":"2015","unstructured":"Palomo T, Fassier F, Ouellet J, Sato A, Montpetit K, Glorieux FH, Rauch F (2015) Intravenous bisphosphonate therapy of young children with osteogenesis imperfecta skeletal findings during follow up throughout the growing years. J Bone Miner Res 30:2150\u20132157. https:\/\/doi.org\/10.1002\/jbmr.2567","journal-title":"J Bone Miner Res"},{"key":"2882_CR48","doi-asserted-by":"publisher","first-page":"e419","DOI":"10.1016\/j.ejmg.2011.03.004","volume":"54","author":"V Bertini","year":"2011","unstructured":"Bertini V, Valetto A, Baroncelli GI, Simi P (2011) Characterization of a complex rearrangement of a chromosome 20 by FISH and array CGH. Eur J Med Genet 54:e419\u2013e424. https:\/\/doi.org\/10.1016\/j.ejmg.2011.03.004","journal-title":"Eur J Med Genet"},{"key":"2882_CR49","doi-asserted-by":"publisher","first-page":"2691","DOI":"10.1007\/s00198-017-4094-0","volume":"28","author":"F Lv","year":"2017","unstructured":"Lv F, Ma M, Liu W, Xu X, Song Y, Li L, Jiang Y, Wang O, Xia W, Xing X, Qiu Z, Li M (2017) Novel large fragment deletion in PLS3 causes rare X-linked early-onset osteoporosis and response to zoledronic acid. Osteoporos Int 28:2691\u20132700. https:\/\/doi.org\/10.1007\/s00198-017-4094-0","journal-title":"Osteoporos Int"},{"key":"2882_CR50","doi-asserted-by":"publisher","first-page":"e1225","DOI":"10.1210\/clinem\/dgad611","volume":"109","author":"J Ma","year":"2024","unstructured":"Ma J, Siminoski K, Jaremko JL, Koujok K, Matzinger MA, Shenouda N, Wilson N, Cheng M, Alos N, Atkinson S, Cummings EA, Ho J et al (2024) Vertebral body reshaping after fractures an important index of recovery in glucocorticoid-treated children. J Clin Endocrinol Metab 109:e1225\u2013e1237. https:\/\/doi.org\/10.1210\/clinem\/dgad611","journal-title":"J Clin Endocrinol Metab"},{"key":"2882_CR51","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1007\/s00198-016-3774-5","volume":"28","author":"J Ma","year":"2017","unstructured":"Ma J, McMillan HJ, Karag\u00fczel G, Goodin G, Wasson J, Matzinger MA, DesClouds P, Cram D, Page M, Konji VN, Lentle WLM (2017) The time to and determinants of first fractures in boys with Duchenne muscular dystrophy. Osteoporos Int 28:597\u2013608. https:\/\/doi.org\/10.1007\/s00198-016-3774-5","journal-title":"Osteoporos Int"},{"key":"2882_CR52","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000207948","volume":"102","author":"E Landfeldt","year":"2024","unstructured":"Landfeldt E, Phung K, Zaman F, Astrom E, Abner S, Lochmuller H, Sejersen T, Ward LM (2024) Bisphosphonates in glucocorticoid-treated patients with Duchenne muscular dystrophy. A systematic review and grading of the evidence. Neurol 102:e207948. https:\/\/doi.org\/10.1212\/WNL.0000000000207948","journal-title":"Neurol"},{"key":"2882_CR53","doi-asserted-by":"publisher","first-page":"710","DOI":"10.1002\/mus.27416","volume":"64","author":"N Nasomyont","year":"2021","unstructured":"Nasomyont N, Tian C, Hornung L, Khoury J, Hochwalt PM, Tilden JC, Wong BL, Rutter MM (2021) The effect of oral bisphosphonate therapy on vertebral morphometry and fractures in patients with Duchenne muscular dystrophy and glucocorticoid-induced osteoporosis. Muscle Nerve 64:710\u2013716. https:\/\/doi.org\/10.1002\/mus.27416","journal-title":"Muscle Nerve"},{"key":"2882_CR54","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1007\/s00198-023-06951-z","volume":"35","author":"E Loscalzo","year":"2024","unstructured":"Loscalzo E, See J, Bharill S, Yousefzadeh N, Gough E, Wu M, Crane JL (2024) Growth hormone and testosterone delay vertebral fractures in boys with muscular dystrophy on chronic glucocorticoids. Osteoporos Int 35:327\u2013338. https:\/\/doi.org\/10.1007\/s00198-023-06951-z","journal-title":"Osteoporos Int"},{"key":"2882_CR55","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1177\/22143602241303370","volume":"12","author":"LM Ward","year":"2025","unstructured":"Ward LM, Weber DR, Wong SC, Apkon S, Clemens PR, Cripe LH, McMillan HJ, Mercuri E, Nasomyont N, Phung K, Renthal NE, Rutter MM, On behalf the International OPTIMIZE DMD Consortium et al (2025) A parent project muscular dystrophy-sponsored international workshop report on endocrine and bone issues in patients with Duchenne muscular dystrophy: an ever-changing landscape. J Neuromuscul Dis 12:116\u2013133. https:\/\/doi.org\/10.1177\/22143602241303370","journal-title":"J Neuromuscul Dis"},{"key":"2882_CR56","doi-asserted-by":"publisher","first-page":"1547","DOI":"10.1007\/s00198-008-0832-7","volume":"20","author":"S Kerkeni","year":"2009","unstructured":"Kerkeni S, Kolta S, Fechtenbaum J, Roux C (2009) Spinal deformity index (SDI) is a good predictor of incident vertebral fractures. Osteoporos Int 20:1547\u20131552. https:\/\/doi.org\/10.1007\/s00198-008-0832-7","journal-title":"Osteoporos Int"},{"key":"2882_CR57","doi-asserted-by":"publisher","DOI":"10.1016\/j.bonr.2022.101595","volume":"16","author":"R Montero-Lopez","year":"2022","unstructured":"Montero-Lopez R, Laurer E, Tischlinger K, Nagy D, Scala M, Kranewitter W, Webersinke G, Hortenhuber T, Hogler W (2022) Spontaneous reshaping of vertebral fractures in an adolescent with Osteogenesis Imperfecta. Bone Rep 16:101595. https:\/\/doi.org\/10.1016\/j.bonr.2022.101595","journal-title":"Bone Rep"},{"key":"2882_CR58","doi-asserted-by":"publisher","first-page":"3607","DOI":"10.1007\/s00198-016-3709-1","volume":"27","author":"G Bardai","year":"2016","unstructured":"Bardai G, Moffatt P, Glorieux FH, Rauch F (2016) DNA sequence analysis in 598 individuals with a clinical diagnosis of osteogenesis imperfecta: diagnostic yield and mutation spectrum. Osteoporos Int 27:3607\u20133613. https:\/\/doi.org\/10.1007\/s00198-016-3709-1","journal-title":"Osteoporos Int"},{"key":"2882_CR59","doi-asserted-by":"publisher","first-page":"1607","DOI":"10.1212\/01.wnl.0000260974.41514.83","volume":"68","author":"WM King","year":"2007","unstructured":"King WM, Ruttencutter R, Nagaraja HN, Matkovic V, Landoll J, Hoyle C, Mendell JR, Kissel JT (2007) Orthopedic outcomes of long-term daily corticosteroid treatment in Duchenne muscular dystrophy. Neurol 68:1607\u20131613. https:\/\/doi.org\/10.1212\/01.wnl.0000260974.41514.83","journal-title":"Neurol"},{"key":"2882_CR60","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1159\/000365889","volume":"82","author":"GI Baroncelli","year":"2014","unstructured":"Baroncelli GI, Bertelloni S (2014) The use of bisphosphonates in pediatrics. Horm Res Paediatr 82:290\u2013302. https:\/\/doi.org\/10.1159\/000365889","journal-title":"Horm Res Paediatr"},{"key":"2882_CR61","doi-asserted-by":"publisher","DOI":"10.1007\/s11657-025-01515-6","volume":"20","author":"YY Wang","year":"2025","unstructured":"Wang YY, Su YC, Lai PC, Chou YY, Wu PT, Tsai MC, Tai TW, Wu CH, Chang YF, Tu YK, Fang CJ, Lin CJ et al (2025) Optimizing bone health with bisphosphonate therapies in pediatric Osteogenesis Imperfecta: a network meta\u2010analysis of randomized trials. Arch Osteoporos 20:33. https:\/\/doi.org\/10.1007\/s11657-025-01515-6","journal-title":"Arch Osteoporos"},{"key":"2882_CR62","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1038\/nrrheum.2013.45","volume":"9","author":"O Makitie","year":"2013","unstructured":"Makitie O (2013) Causes, mechanisms and management of paediatric osteoporosis. Nat Rev Rheumatol 9:465\u2013475. https:\/\/doi.org\/10.1038\/nrrheum.2013.45","journal-title":"Nat Rev Rheumatol"},{"key":"2882_CR63","doi-asserted-by":"publisher","first-page":"2198","DOI":"10.1002\/jbmr.3833","volume":"34","author":"ME Robinson","year":"2019","unstructured":"Robinson ME, Trejo P, Palomo T, Glorieux FH, Rauch F (2019) Osteogenesis Imperfecta: skeletal outcomes after bisphosphonate discontinuation at final height. J Bone Miner Res 34:2198\u20132204. https:\/\/doi.org\/10.1002\/jbmr.3833","journal-title":"J Bone Miner Res"},{"key":"2882_CR64","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1007\/s11914-020-00621-3","volume":"18","author":"MR Celin","year":"2020","unstructured":"Celin MR, Simon JC, Krzak JJ, Fial AV, Kruger KM, Smith PA, Harris GF (2020) Do bisphosphonates alleviate pain in children? a systematic review. Curr Osteoporos Rep 18:486\u2013504. https:\/\/doi.org\/10.1007\/s11914-020-00621-3","journal-title":"Curr Osteoporos Rep"},{"key":"2882_CR65","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2023.1082413","volume":"14","author":"D Madhuchani","year":"2023","unstructured":"Madhuchani D, Seneviratne SN, Ward LM (2023) Bone health in childhood and adolescence: an overview on dual-energy X-ray absorptiometry scanning, fracture surveillance and bisphosphonate therapy for low-middle-income countries. Front Endocrinol 14:1082413. https:\/\/doi.org\/10.3389\/fendo.2023.1082413","journal-title":"Front Endocrinol"},{"key":"2882_CR66","doi-asserted-by":"publisher","first-page":"821","DOI":"10.1016\/j.bone.2006.11.020","volume":"40","author":"F Rauch","year":"2007","unstructured":"Rauch F, Cornibert S, Cheung M, Glorieux FH (2007) Long-bone changes after pamidronate discontinuation in children and adolescents with Osteogenesis Imperfecta. Bone 40:821\u2013827. https:\/\/doi.org\/10.1016\/j.bone.2006.11.020","journal-title":"Bone"},{"key":"2882_CR67","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1093\/rheumatology\/ket236","volume":"53","author":"E Suresh","year":"2014","unstructured":"Suresh E, Pazianas M, Abrahamsen B (2014) Safety issues with bisphosphonate therapy for osteoporosis. Rheumatol 53:19\u201331. https:\/\/doi.org\/10.1093\/rheumatology\/ket236","journal-title":"Rheumatol"},{"key":"2882_CR68","doi-asserted-by":"publisher","first-page":"960","DOI":"10.1007\/s00223-024-01305-1","volume":"115","author":"L Celli","year":"2024","unstructured":"Celli L, Garrelfs MR, Sakkers RJB, Elting MW, Celli M, B\u00f6kenkamp A, Smits C, Goderie T, Smit JM, Schwarte LA, Schober PR, Lubbers WD et al (2024) Adapting to adulthood: a review of transition strategies for osteogenesis imperfecta. Calcif Tissue Int 115:960\u2013975. https:\/\/doi.org\/10.1007\/s00223-024-01305-1","journal-title":"Calcif Tissue Int"},{"key":"2882_CR69","doi-asserted-by":"publisher","first-page":"1511","DOI":"10.2106\/JBJS.F.00726","volume":"89","author":"M Al Muderis","year":"2007","unstructured":"Al Muderis M, Azzopardi T, Cundy P (2007) Zebra lines of pamidronate therapy in children. J Bone Joint Surg Am 89:1511\u20131516. https:\/\/doi.org\/10.2106\/JBJS.F.00726","journal-title":"J Bone Joint Surg Am"},{"key":"2882_CR70","doi-asserted-by":"publisher","first-page":"849","DOI":"10.1136\/archdischild-2023-326287","volume":"109","author":"S Nayak","year":"2024","unstructured":"Nayak S, Rayner L, Mughal Z, McKinney G, Mason A, Wong SC, Padidela R, Chinoy A (2024) Severity of acute phase reaction in children receiving the first dose of zoledronic acid and the impact of the underlying condition: a cross-sectional study. Arch Dis Child 109:849\u2013853. https:\/\/doi.org\/10.1136\/archdischild-2023-326287","journal-title":"Arch Dis Child"},{"key":"2882_CR71","doi-asserted-by":"publisher","first-page":"1005","DOI":"10.1001\/jamaneurol.2022.2480","volume":"79","author":"M Guglieri","year":"2022","unstructured":"Guglieri M, Clemens PR, Perlman SJ, Smith EC, Horrocks I, Finkel RS, Mah JK, Deconinck N, Goemans N, Haberlova J, Straub V, Mengle-Gaw LJ et al (2022) Efficacy and safety of vamorolone vs placebo and prednisone among boys with Duchenne muscular dystrophy: a randomized clinical trial. JAMA Neurol 79:1005\u20131014. https:\/\/doi.org\/10.1001\/jamaneurol.2022.2480","journal-title":"JAMA Neurol"},{"key":"2882_CR72","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1359\/jbmr.090819","volume":"25","author":"F Bertoldo","year":"2010","unstructured":"Bertoldo F, Pancheri S, Zenari S, Boldini S, Giovanazzi B, Zanatta M, Valenti MT, Dalle Carbonare L, Lo Cascio V (2010) Serum 25-hydroxyvitamin D levels modulate the acute- phase response associated with the first nitrogen-containing bisphosphonate infusion. J Bone Miner Res 25:447\u2013454. https:\/\/doi.org\/10.1359\/jbmr.090819","journal-title":"J Bone Miner Res"},{"key":"2882_CR73","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1002\/jbmr.290","volume":"26","author":"T Srivastava","year":"2011","unstructured":"Srivastava T, Dai H, Haney CJ, Alon US (2011) Serum 25-hydroxyvitamin D level and acute-phase reaction following initial intravenous bisphosphonate. J Bone Miner Res 26:437\u2013438. https:\/\/doi.org\/10.1002\/jbmr.290","journal-title":"J Bone Miner Res"},{"key":"2882_CR74","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1055\/s-0039-1700972","volume":"9","author":"E Maines","year":"2020","unstructured":"Maines E, Tadiotto E, Morandi G, Fedrizzi M, Gaudino R, Cavarzere P, Guzzo A, Antoniazzi F (2020) Hypocalcemia following neridronate administration in pediatric patients with osteogenesis imperfecta: a prospective observational study. J Pediatr Genet 9:93\u2013100. https:\/\/doi.org\/10.1055\/s-0039-1700972","journal-title":"J Pediatr Genet"},{"key":"2882_CR75","doi-asserted-by":"publisher","first-page":"3768","DOI":"10.1210\/jc.2009-2814","volume":"95","author":"A Rothenbuhler","year":"2010","unstructured":"Rothenbuhler A, Marchand I, Bougn\u00e8res P, Linglart A (2010) Risk of corrected QT interval prolongation after pamidronate infusion in children. J Clin Endocrinol Metab 95:3768\u20133770. https:\/\/doi.org\/10.1210\/jc.2009-2814","journal-title":"J Clin Endocrinol Metab"},{"key":"2882_CR76","doi-asserted-by":"publisher","first-page":"1679","DOI":"10.1002\/jbmr.4911","volume":"38","author":"A Shoung","year":"2023","unstructured":"Shoung A, Shoung N, Hii R, Nerlekar N, Ebeling PR, Rodr\u00edguez AJ (2023) Electrocardiogram changes following intravenous bisphosphonate infusion: a systematic review and meta-analysis. J Bone Miner Res 38:1679\u20131688. https:\/\/doi.org\/10.1002\/jbmr.4911","journal-title":"J Bone Miner Res"},{"key":"2882_CR77","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1007\/s00774-013-0438-9","volume":"31","author":"GI Baroncelli","year":"2013","unstructured":"Baroncelli GI, Vierucci F, Bertelloni S, Erba P, Zampollo E, Giuca MR (2013) Pamidronate treatment stimulates the onset of recovery phase reducing fracture rate and skeletal deformities in patients with idiopathic juvenile osteoporosis: comparison with untreated patients. J Bone Miner Metab 31:533\u2013543. https:\/\/doi.org\/10.1007\/s00774-013-0438-9","journal-title":"J Bone Miner Metab"},{"key":"2882_CR78","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1210\/jc.2010-2704","volume":"96","author":"AC Ross","year":"2011","unstructured":"Ross AC, Manson JE, Abrams SA, Aloia JF, Brannon PM, Clinton SK, Durazo-Arvizu RA, Gallagher JC, Gallo RL, Jones G, Kovacs CS, Mayne ST et al (2011) The 2011 report on dietary reference intakes for calcium and vitamin D from the institute of medicine: what clinicians need to know. J Clin Endocrinol Metab 96:53\u201358. https:\/\/doi.org\/10.1210\/jc.2010-2704","journal-title":"J Clin Endocrinol Metab"},{"key":"2882_CR79","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1093\/qjmed\/hcq039","volume":"103","author":"G Liamis","year":"2010","unstructured":"Liamis G, Milionis HJ, Elisaf M (2010) Medication-induced hypophosphatemia: a review. Q J Med 103:449\u2013459. https:\/\/doi.org\/10.1093\/qjmed\/hcq039","journal-title":"Q J Med"},{"key":"2882_CR80","doi-asserted-by":"publisher","first-page":"1030","DOI":"10.1542\/peds.111.5.1030","volume":"111","author":"L Zeitlin","year":"2003","unstructured":"Zeitlin L, Rauch F, Plotkin H, Glorieux FH (2003) Height and weight development during four years of therapy with cyclical intravenous pamidronate in children and adolescents with osteogenesis imperfecta types I, III, and IV. Pediatrics 111:1030\u20131036. https:\/\/doi.org\/10.1542\/peds.111.5.1030","journal-title":"Pediatrics"},{"key":"2882_CR81","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1038\/s41436-018-0045-1","volume":"21","author":"M Jain","year":"2019","unstructured":"Jain M, Tam A, Shapiro JR, Steiner RD, Smith PA, Bober MB, Hart T, Cuthbertson D, Krischer J, Mullins M, Bellur S, Byers PH et al (2019) Growth characteristics in individuals with osteogenesis imperfecta in North America: results from a multicenter study. Genet Med 21:275\u2013283. https:\/\/doi.org\/10.1038\/s41436-018-0045-1","journal-title":"Genet Med"},{"key":"2882_CR82","doi-asserted-by":"publisher","first-page":"1034","DOI":"10.1002\/jbmr.3071","volume":"32","author":"P Trejo","year":"2017","unstructured":"Trejo P, Fassier F, Glorieux FH, Rauch F (2017) Diaphyseal femur fractures in osteogenesis imperfecta characteristics and relationship with bisphosphonate treatment. J Bone Miner Res 32:1034\u20131039. https:\/\/doi.org\/10.1002\/jbmr.3071","journal-title":"J Bone Miner Res"},{"key":"2882_CR83","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1002\/jbm4.10024","volume":"2","author":"HH Nguyen","year":"2018","unstructured":"Nguyen HH, van de Laarschot DM, Verkerk AJMH, Milat F, Zillikens MC, Ebeling PR (2018) Genetic risk factors for atypical femoral fractures (AFFs): a systematic review. JBMR Plus 2:1\u201311. https:\/\/doi.org\/10.1002\/jbm4.10024","journal-title":"JBMR Plus"},{"key":"2882_CR84","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1007\/s11914-021-00658-y","volume":"19","author":"W Zhou","year":"2021","unstructured":"Zhou W, van Rooij JGJ, Ebeling PR, Verkerk AJMH, Zillikens MC (2021) The genetics of atypical femur fractures a systematic review. Curr Osteoporos Rep 19:123\u2013130. https:\/\/doi.org\/10.1007\/s11914-021-00658-y","journal-title":"Curr Osteoporos Rep"},{"key":"2882_CR85","doi-asserted-by":"publisher","DOI":"10.5037\/jomr.2013.4401","volume":"4","author":"AA Hennedige","year":"2013","unstructured":"Hennedige AA, Jayasinghe J, Khajeh J, Macfarlane TV (2013) Systematic review on the incidence of bisphosphonate related osteonecrosis of the jaw in children diagnosed with osteogenesis imperfecta. J Oral Maxillofac Res 4:e1. https:\/\/doi.org\/10.5037\/jomr.2013.4401","journal-title":"J Oral Maxillofac Res"},{"key":"2882_CR86","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1016\/j.ijom.2019.08.004","volume":"49","author":"NT Duarte","year":"2020","unstructured":"Duarte NT, de Oliveira Rech B, Godoy Martins I, Bertoldi Franco J, Lopez Ortega K (2020) Can children be affected by bisphosphonate-related osteonecrosis of the jaw? a systematic review. Int J Oral Maxillofac Surg 49:183\u2013191. https:\/\/doi.org\/10.1016\/j.ijom.2019.08.004","journal-title":"Int J Oral Maxillofac Surg"},{"key":"2882_CR87","doi-asserted-by":"publisher","DOI":"10.3390\/jcm12041416","volume":"12","author":"HD Rosales","year":"2023","unstructured":"Rosales HD, Guevara HG, Requejo S, Jensen MD, Acero J, Olate S (2023) Medication-related osteonecrosis of the jaws (MRONJ) in children and young patients. A systematic review. J Clin Med 12:1416","journal-title":"J Clin Med"},{"key":"2882_CR88","doi-asserted-by":"publisher","first-page":"1285","DOI":"10.1016\/j.joms.2024.06.162","volume":"82","author":"S Lasky","year":"2024","unstructured":"Lasky S, Moshal T, Shakoori P, Roohani I, Jolibois M, Youn S, Urata MM, Hammoudeh JA (2024) The risk of medication-related osteonecrosis of the ]aw in children guidance for antiresorptive use in pediatric patients. J Oral Maxillofac Surg 82:1285\u20131294. https:\/\/doi.org\/10.1016\/j.joms.2024.06.162","journal-title":"J Oral Maxillofac Surg"},{"key":"2882_CR89","doi-asserted-by":"publisher","first-page":"920","DOI":"10.1016\/j.joms.2022.02.008","volume":"80","author":"SL Ruggiero","year":"2022","unstructured":"Ruggiero SL, Dodson TB, Aghaloo T, Carlson ER, Ward BB, Kademani D (2022) American association of oral and maxillofacial surgeons\u2019 position paper on medication-related osteonecrosis of the jaws-2022 update. J Oral Maxillofac Surg 80:920\u2013943. https:\/\/doi.org\/10.1016\/j.joms.2022.02.008","journal-title":"J Oral Maxillofac Surg"},{"key":"2882_CR90","doi-asserted-by":"publisher","first-page":"3679","DOI":"10.1111\/odi.14887","volume":"30","author":"A Bedogni","year":"2024","unstructured":"Bedogni A, Mauceri R, Fusco V, Bertoldo F, Bettini G, Di Fede O, Lo Casto A, Marchetti C, Panzanella V, Saia G, Vescovi P, Campisi G (2024) Italian position paper (SIPMO-SICMF) on medication-related osteonecrosis of the jaw (MRONJ). Oral Dis 30:3679\u20133709. https:\/\/doi.org\/10.1111\/odi.14887","journal-title":"Oral Dis"},{"key":"2882_CR91","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1111\/adj.12140","volume":"59","author":"RN Bhatt","year":"2014","unstructured":"Bhatt RN, Hibbert SA, Munns CF (2014) The use of bisphosphonates in children review of the literature and guidelines for dental management. Aust Dent J 59:9\u201319. https:\/\/doi.org\/10.1111\/adj.12140","journal-title":"Aust Dent J"},{"key":"2882_CR92","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1016\/B978-0-12-382040-2.10019-X","volume-title":"Pediatric bone. biology and diseases","author":"F Glorieux","year":"2012","unstructured":"Glorieux F, Rowe D (2012) Osteogenesis imperfecta. In: Glorieux FH, Pettifor JM, Juppner H (eds) Pediatric bone. biology and diseases, 2nd edition. Academic Press-Elsevier, USA, pp 511\u2013539","edition":"2nd edition"},{"key":"2882_CR93","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1359\/jbmr.2003.18.2.237","volume":"18","author":"JC Marini","year":"2003","unstructured":"Marini JC, Hopkins E, Glorieux FH, Chrousos GP, Reynolds JC, Gundberg CM, Reing CM (2003) Positive linear growth and bone responses to growth hormone treatment in children with types III and IV osteogenesis imperfecta: high predictive value of the carboxyterminal propeptide of type I procollagen. J Bone Miner Res 18:237\u2013243. https:\/\/doi.org\/10.1359\/jbmr.2003.18.2.237","journal-title":"J Bone Miner Res"},{"key":"2882_CR94","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1530\/EJE-10-0208","volume":"163","author":"F Antoniazzi","year":"2010","unstructured":"Antoniazzi F, Monti E, Venturi G, Franceschi R, Doro F, Gatti D, Zamboni G, Tat\u00f2 L (2010) GH in combination with bisphosphonate treatment in osteogenesis imperfecta. Eur J Endocrinol 163:479\u2013487. https:\/\/doi.org\/10.1530\/EJE-10-0208","journal-title":"Eur J Endocrinol"},{"key":"2882_CR95","doi-asserted-by":"publisher","DOI":"10.1186\/s13023-014-0145-1","volume":"9","author":"H Hoyer-Kuhn","year":"2014","unstructured":"Hoyer-Kuhn H, Netzer C, Koerber F, Schoenau E, Semler O (2014) Two years\u2019 experience with denosumab for children with osteogenesis imperfecta type VI. Orphanet J Rare Dis 9:145. https:\/\/doi.org\/10.1186\/s13023-014-0145-1","journal-title":"Orphanet J Rare Dis"},{"key":"2882_CR96","doi-asserted-by":"publisher","first-page":"1827","DOI":"10.1210\/clinem\/dgad732","volume":"109","author":"J Liu","year":"2024","unstructured":"Liu J, Lin X, Sun L, Zhang Q, Jiang Y, Wang O, Xing X, Xia W, Li M (2024) Safety and efficacy of denosumab in children with osteogenesis imperfecta: the first prospective comparative study. J Clin Endocrinol Metab 109:1827\u20131836. https:\/\/doi.org\/10.1210\/clinem\/dgad732","journal-title":"J Clin Endocrinol Metab"},{"key":"2882_CR97","doi-asserted-by":"publisher","first-page":"1445093","DOI":"10.3389\/fendo.2025.1445093","volume":"16","author":"Y Mei","year":"2025","unstructured":"Mei Y, Cai S, Jiang Y, TianY SL, Gu J, Wang C, Zhang Z, Zhang H (2025) Denosumab in patients with osteogenesis imperfecta and a historical control study with alendronate. Front Endocrinol 16:1445093. https:\/\/doi.org\/10.3389\/fendo.2025.1445093","journal-title":"Front Endocrinol"},{"key":"2882_CR98","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1007\/s00431-022-04743-x","volume":"182","author":"S Ciancia","year":"2023","unstructured":"Ciancia S, Hogler W, Sakkers RJB, Appelman-Dijkstra NM, Boot AM, Sas TCJ, Renes JS (2023) Osteoporosis in children and adolescents: how to treat and monitor? Eur J Pediatr 182:501\u2013511","journal-title":"Eur J Pediatr"},{"key":"2882_CR99","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1515\/jpem-2024-0512","volume":"38","author":"S Stasek","year":"2025","unstructured":"Stasek S, Zaucke F, Hoyer-Kuhn H, Etich J, Reincke S, Arndt I, Rehberg M, Semler O (2025) Osteogenesis imperfecta: shifting paradigms in pathophysiology and care in children. J Pediatr Endocrinol Metab 38:1\u201315. https:\/\/doi.org\/10.1515\/jpem-2024-0512","journal-title":"J Pediatr Endocrinol Metab"},{"key":"2882_CR100","unstructured":"Setrusumab vs bisphosphonates in pediatric subjects with osteogenesis imperfecta (Cosmic). https:\/\/clinicaltrials.gov\/study\/NCT05768854. Accessed March 6, 2026"},{"key":"2882_CR101","doi-asserted-by":"publisher","first-page":"1215","DOI":"10.1093\/jbmr\/zjae112","volume":"39","author":"FH Glorieux","year":"2024","unstructured":"Glorieux FH, Langdahl B, Chapurlat R, Jan De Beur S, Sutton VR, Poole KES, Dahir KM, Orwoll ES, Willie BM, Mikolajewicz N, Zimmermann E, Hosseinitabatabaei S et al (2024) Setrusumab for the treatment of osteogenesis imperfecta 12-month results from the phase 2b asteroid study. J Bone Miner Res 39:1215\u20131228. https:\/\/doi.org\/10.1093\/jbmr\/zjae112","journal-title":"J Bone Miner Res"},{"key":"2882_CR102","unstructured":"Study to evaluate efficacy and safety of Romosozumab compared with bisphosphonates in children and adolescents with osteogenesis imperfecta. n.d. https:\/\/clinicaltrials.gov\/study\/NCT05972551. Accessed March 6 2026"},{"key":"2882_CR103","doi-asserted-by":"publisher","first-page":"e73","DOI":"10.1097\/BPO.0000000000002524","volume":"44","author":"V Eaton","year":"2024","unstructured":"Eaton V, Braaten M, Schissel M, Wallace M (2024) Assessing the safety and efficacy of tranexamic acid usage in osteogenesis imperfecta patients. J Pediatr Orthop 44:e73\u2013e78. https:\/\/doi.org\/10.1097\/BPO.0000000000002524","journal-title":"J Pediatr Orthop"},{"key":"2882_CR104","first-page":"530","volume":"21","author":"BD Warady","year":"1994","unstructured":"Warady BD, Lindsley CB, Robinson FG, Lukert BP (1994) Effects of nutritional supplementation on bone mineral status of children wit8006898h rheumatic diseases receiving corticosteroid therapy. J Rheumatol 21:530\u2013535","journal-title":"J Rheumatol"},{"key":"2882_CR105","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1097\/MPH.0000000000001155","volume":"40","author":"KM Williams","year":"2018","unstructured":"Williams KM, Lee MT, Licursi M, Brittenham GM, Fennoy I (2018) Response to long-term vitamin D therapy for bone disease in children with sickle cell disease. J Pediatr Hematol Oncol 40:458\u2013461. https:\/\/doi.org\/10.1097\/MPH.0000000000001155","journal-title":"J Pediatr Hematol Oncol"},{"key":"2882_CR106","doi-asserted-by":"publisher","first-page":"2328","DOI":"10.1210\/clinem\/dgab302","volume":"106","author":"M Zacharin","year":"2021","unstructured":"Zacharin M, Lim A, Gryllakis J, Siafarikas A, Jefferies C, Briody J, Heather N, Pitkin J, Emmanuel J, Lee KJ, Wang X, Simm PJ et al (2021) Randomized controlled trial evaluating the use of zoledronic acid in Duchenne muscular dystrophy. J Clin Endocrinol Metab 106:2328\u20132342. https:\/\/doi.org\/10.1210\/clinem\/dgab302","journal-title":"J Clin Endocrinol Metab"},{"key":"2882_CR107","doi-asserted-by":"publisher","first-page":"e1229","DOI":"10.1542\/peds.2014-2173","volume":"134","author":"NH Golden","year":"2014","unstructured":"Golden NH, Abrams SA, Committe on Nutrition (2014) Optimizing bone health in children and adolescents. Pediatrics 134:e1229\u2013e1243. https:\/\/doi.org\/10.1542\/peds.2014-2173","journal-title":"Pediatrics"},{"key":"2882_CR108","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1159\/000381047","volume-title":"Calcium and bone disorders in children and adolescents","author":"S Korula","year":"2015","unstructured":"Korula S, Titmuss AT, Biggin A, Munns CF (2015) A practical approach to children with recurrent fractures. In: Allgrove J, Shaw NJ (eds) Calcium and bone disorders in children and adolescents, 2nd revised edn. Karger, Basel (Switzerland), pp 210\u2013225","edition":"2nd revised edn"},{"key":"2882_CR109","doi-asserted-by":"publisher","first-page":"820","DOI":"10.1210\/er.2014-1007","volume":"35","author":"JP Bonjour","year":"2014","unstructured":"Bonjour JP, Chevalley T (2014) Pubertal timing, bone acquisition, and risk of fracture throughout life. Endocr Rev 35:820\u2013847. https:\/\/doi.org\/10.1210\/er.2014-1007","journal-title":"Endocr Rev"},{"key":"2882_CR110","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1002986","volume":"16","author":"L Vandenput","year":"2019","unstructured":"Vandenput L, Kindblom JM, Bygdell M, Nethander M, Ohlsson C (2019) Pubertal timing and adult fracture risk in men a population-based cohort study. PLoS Med 16:e1002986. https:\/\/doi.org\/10.1371\/journal.pmed.1002986","journal-title":"PLoS Med"},{"key":"2882_CR111","doi-asserted-by":"publisher","first-page":"2385","DOI":"10.1007\/s40618-022-01859-7","volume":"45","author":"AM Isidori","year":"2022","unstructured":"Isidori AM, Aversa A, Calogero A, Ferlin A, Francavilla S, Lanfranco F, Pivonello R, Rochira V, Corona G, Maggi M (2022) Adult- and late-onset male hypogonadism the clinical practice guidelines of the Italian Society of Andrology and Sexual Medicine (SIAMS) and the Italian Society of Endocrinology (SIE). J Endocrinol Invest 45:2385\u20132403. https:\/\/doi.org\/10.1007\/s40618-022-01859-7","journal-title":"J Endocrinol Invest"},{"key":"2882_CR112","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1111\/cen.15097","volume":"101","author":"CN Jayasena","year":"2024","unstructured":"Jayasena CN, Devine K, Barber K, Comninos AN, Conway GS, Crown A, Davies M, Ewart A, Seal LJ, Smyth A, Turner HE, Webber L et al (2024) Society for endocrinology guideline for understanding, diagnosing and treating female hypogonadism. Clin Endocrinol 101:409\u2013442. https:\/\/doi.org\/10.1111\/cen.15097","journal-title":"Clin Endocrinol"},{"key":"2882_CR113","doi-asserted-by":"publisher","first-page":"458","DOI":"10.4274\/jcrpe.galenos.2024.2024-2-18","volume":"16","author":"S McCarrison","year":"2024","unstructured":"McCarrison S, Denker M, Dunne J, Horrocks I, McNeilly J, Joseph S, Wong S (2024) Frequency of delayed puberty in boys with contemporary management of duchenne muscular dystrophy. J Clin Res Pediatr Endocrinol 16:458\u2013465. https:\/\/doi.org\/10.4274\/jcrpe.galenos.2024.2024-2-18","journal-title":"J Clin Res Pediatr Endocrinol"},{"key":"2882_CR114","doi-asserted-by":"publisher","DOI":"10.1016\/j.jposna.2024.100060","volume":"7","author":"LN Rhodes","year":"2024","unstructured":"Rhodes LN, Diaz-Thomas A, Woodland WH, Sawyer JR, Spence DD, Warner WC (2024) Assessment and management of low bone mineral density in children with cerebral palsy. J Pediatr Orthop Soc North Am 7:100060. https:\/\/doi.org\/10.1016\/j.jposna.2024.100060","journal-title":"J Pediatr Orthop Soc North Am"},{"key":"2882_CR115","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1515\/jpem-2024-0013","volume":"37","author":"A Trinh","year":"2024","unstructured":"Trinh A, Lim A, Wong P, Brown J, Pitkin J, Wollenhoven B, Ebeling P, Fuller P, Milat F, Zacharin M (2024) A pilot study proposing an algorithm for pubertal induction in cerebral palsy. J Pediatr Endocrinol Metab 37:222\u2013227. https:\/\/doi.org\/10.1515\/jpem-2024-0013","journal-title":"J Pediatr Endocrinol Metab"},{"key":"2882_CR116","doi-asserted-by":"publisher","first-page":"2542","DOI":"10.1080\/09638288.2019.1573932","volume":"42","author":"M Wouters","year":"2020","unstructured":"Wouters M, Evenhuis HM, Hilgenkamp TIM (2020) Physical fitness of children and adolescents with moderate to severe intellectual disabilities. Disabil Rehabil 42:2542\u20132552. https:\/\/doi.org\/10.1080\/09638288.2019.1573932","journal-title":"Disabil Rehabil"},{"key":"2882_CR117","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1302\/2633-1462.65.BJO-2024-0268","volume":"6","author":"S Hopewell","year":"2025","unstructured":"Hopewell S, Keene DJ, Marian I, Perry DC, Rombach I, Andrew M, Barry C, Davis L, Firth G, Fletcher H, Fordham B, Osborne VG et al (2025) Clinical effectiveness of an individually tailored strengthening programme, including progressive resistance exercises and advice, compared to usual care for ambulant adolescents with spastic cerebral palsy (ROBUST trial) a parallel group randomized controlled trial. Bone Jt Open 6:517\u2013527","journal-title":"Bone Jt Open"},{"key":"2882_CR118","doi-asserted-by":"publisher","DOI":"10.1016\/j.arrct.2023.100298","volume":"5","author":"D Godley","year":"2023","unstructured":"Godley D, Csongradi J (2023) Whole body vibration therapy for children with disabilities a survey of potential risks and benefits. Arch Rehabil Res Clin Transl 5:100298. https:\/\/doi.org\/10.1016\/j.arrct.2023.100298","journal-title":"Arch Rehabil Res Clin Transl"}],"container-title":["Journal of Endocrinological Investigation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40618-026-02882-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40618-026-02882-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40618-026-02882-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,21]],"date-time":"2026-08-21T06:08:50Z","timestamp":1787292530000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40618-026-02882-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,24]]},"references-count":118,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2026,9]]}},"alternative-id":["2882"],"URL":"https:\/\/doi.org\/10.1007\/s40618-026-02882-8","relation":{},"ISSN":["1720-8386"],"issn-type":[{"value":"1720-8386","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,24]]},"assertion":[{"value":"12 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"All Authors have no conflict of interest to declare.","order":1,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The paper is based on literature data and clinical expertise and did not require ethics committee approval.","order":2,"name":"Ethics","label":"Ethical","group":{"name":"EthicsHeading","label":"Declarations"}}]}}